Who is eligible for clinical trial NCT00745355?

Participants must meet protocol criteria for Bladder Cancer. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT00745355 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-05-29

Quality of Life in Patients With Bladder Cancer (NCT00745355)

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Memorial Sloan Kettering Cancer Center

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (7 items) and avoid the listed exclusions (4 items).

Location: Memorial Sloan-Kettering Cancer Center — New York, New York

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

All patients (male and female) who are diagnosed with bladder cancer
Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy.
Participants must be able to speak English.
Participants must be able to provide informed consent.
Participants must be 18 years of age or older to enroll.
Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy.
Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon).

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Subjects may be excluded from the study based on the following criteria:
Follow-up care not obtained at MSKCC.
Metastatic disease at diagnosis.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Memorial Sloan-Kettering Cancer Center — New York, New York

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗